Your browser doesn't support javascript.
loading
CT-guided infiltration of greater occipital nerve for refractory craniofacial pain syndromes other than occipital neuralgia.
Ricquart Wandaele, A; Kastler, A; Comte, A; Hadjidekov, G; Kechidi, R; Helenon, O; Kastler, B.
Afiliação
  • Ricquart Wandaele A; Radiology Department, Nord Franche Comté Hospital, 90000 Belfort, France.
  • Kastler A; Neuroradiology and MRI Unit, Grenoble Alpes University Hospital, 38000 Grenoble, France. Electronic address: kastler.radio@gmail.com.
  • Comte A; Functional Imaging Research Department, University Hospital Jean-Minjoz, 25000 Besançon, France.
  • Hadjidekov G; Department of Radiology, University Hospital Lozenets, 1407 Sofia, Bulgaria.
  • Kechidi R; Department of Musculoskeletal Radiology, Hopital Central, Nancy University Hospital, 54000 Nancy, France.
  • Helenon O; Adult Radiology Department, Necker Hospital, Assistance-Publique-Hopitaux de Paris, Université de Paris, 75006 Paris, France.
  • Kastler B; Adult Radiology Department, Necker Hospital, Assistance-Publique-Hopitaux de Paris, Université de Paris, 75006 Paris, France.
Diagn Interv Imaging ; 101(10): 643-648, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32482584
ABSTRACT

PURPOSE:

The purpose of this study was to evaluate the effectiveness of computed tomography (CT)-guided infiltration of greater occipital nerve (GON) for the treatment of refractory craniofacial pain syndromes other than occipital neuralgia. MATERIALS AND

METHODS:

Fifty-six patients suffering from refractory craniofacial pain syndromes were included between 2011 and 2017. There were 33 women and 23 men with a mean age of 50.7 years±13.1 (SD) (range 27-74 years). CT-guided infiltration was performed at the intermediate site of the GON with local anesthetics and cortivazol. Twenty-six (26/56; 46%) patients suffered from chronic migraine, 14 (14/56; 25%) from trigeminal neuralgia and 16 (16/56; 29%) from cluster headaches. Clinical success at 1, 3, and 6 months was defined by a decrease of at least 50% of pain as assessed using visual analog scale (VAS).

RESULTS:

Mean overall VAS score before infiltration was 8.7±1.3 (SD) (range 6 - 10). Mean overall VAS scores after infiltration were 2.3±3 (SD) (range 0 - 10) (P<0.01) at one month, 3.5±3.3 (SD) (range 0 - 10) (P<0.01) at three months and 7.6±1.3 (SD) (range 1-10) (P<0.01) at six months. After infiltration, clinical success was achieved in 44 patients (44/56; 78.5%) at 1 month, 37 patients (37/56; 66%) at 3 months and 13 patients (13/56; 23%) at 6 months. Clinical success according to the clinical presentation were as follows 88% (23/26) at one month, 73% (19/26) at 3 months, and 23% (6/26) at 6 months in patients with chronic migraine, 81% (13/16), 69% (11/16) and 31% (5/16) in those with cluster headaches and 57% (8/14), 50% (7/14) and 14% (2/14) in those with trigeminal neuralgia. No major complications due to CT-guided GON infiltration were reported in any patient.

CONCLUSION:

CT-guided infiltration at the intermediate site of the GON appears as an effective treatment of craniofacial pain syndromes especially in patients with chronic migraine and those with cluster headaches.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuralgia Facial / Neuralgia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuralgia Facial / Neuralgia Idioma: En Ano de publicação: 2020 Tipo de documento: Article